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Abstract
Introduction: Myotonic dystrophy (MD) or Steinert’s syndrome is a rare cause of chronic diarrhea and anal
incontinence. In the presence of chronic diarrhea and fecal incontinence with muscle weakness, neuromuscular
disorders such as myotonic dystrophy should be considered in the differential diagnosis.
Case Presentation: We present the case of a 45-year-old Turkish man with Steinert’s syndrome, who was not
diagnosed until the age of 45.
Conclusions: In clinical practice, the persistence of diarrhea and fecal incontinence with muscle weakness should
suggest that the physician perform an anal manometric study and electromyography. Neuromuscular disorders
such as myotonic dystrophy should be considered in the differential diagnosis.
Introduction
Steinert’s syndrome, also called myotonic dystrophy
(MD), is an autosomal dominant inherited muscular dis-
order which usually presents in early adulthood, is char-
acterized by progressive muscular weakness, myotonia,
frontal baldness, lenticular opacities and testicular atro-
phy. Multi-organ damage may include the heart, endo-
crine system, gastrointestinal system, respiratory system
and the central nervous system. MD is diagnosed with
molecular genetic techniques by demonstration of the
abnormality at the 19q13-2 locus. It is the most frequent
form of adult onset muscular dystrophies with an esti-
mated prevalence of 1/20,000 [1].
Gastrointestinal involvement is frequently observed in
MD. Abnormalities of smooth muscle lead to esophageal
and gastrointestinal motility disorders with mega-eso-
phagus and mega-colon, and rarely incontinence [2,3].
Some studies suggest that neurological factors can play
a role in the digestive symptoms of MD patients [4,5].
Digestive symptoms may be the initial sign of the dis-
ease. In the upper digestive tract dysphagia, heartburn,
regurgitation, and dyspepsia are the most common com-
plaints while in the lower digestive tract abdominal pain,
bloating, constipation and chronic diarrhea are often
reported [6]. Fecal incontinence is a relatively rare
symptom in MD patients.
We present the case of a 45-year-old Turkish man
who presented with chronic diarrhea and fecal inconti-
nence as the initial symptoms to our outpatient clinic
and was later diagnosed with MD.
Case Presentation
A 45-year-old Turkish man presented with diarrhea
three to four times per day, without pus or blood, and
fatigue for the previous six months to our outpatient
Internal Medicine clinic. Diarrhea was frequently com-
bined with fecal incontinence which had a marked nega-
tive impact on his social life. He also described muscle
weakness especially in the proximal parts of his extremi-
ties that had been present for nearly five years. His
walking style had changed and he was having difficulty
while climbing stairs, dressing and performing routine
daily activities. He had not been examined medically for
these complaints before.
He had had libido loss and impotence for the previous
three years for which he had been receiving sildenafil
tablets on occasion. A spermiogram made three years
ago, revealed azoospermia. His family history revealed
that several members of his immediate family had an
undiagnosed neurological disease. One of his parents
had hyperthyroidism and the other suffered from cardiac
arrhythmia.
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normal, his body mass index was 22.7 kg/m
2 (height:
178 cm, weight: 72 kg), and depressed affect was
remarkable. His thyroid gland was non-palpable. Cardio-
vascular and respiratory system examinations were nor-
mal. No organomegaly or rebound tenderness was
detected on abdominal examination. Neurological exam-
ination revealed weakness and atrophy in the neck, face,
and extremity muscles, especially involving his distal
muscles, and tetraparesis, hypo-active deep tendon
reflexes and steppage gait on the right side due to distal
weakness. Bilateral cataract was found on ocular
examination.
Laboratory findings were as follows: whole blood
count was normal; serum levels of glucose: 98 mg/dl,
BUN: 12, creatinin: 0.8 mg/dl, calcium: 9.1 mg/dl, albu-
min: 3.9 mg/dl, sodium: 138 mmol/L, potassium: 4.2
mmol/L, creatine kinase: 315 U/L, free T4: 1.25 ng/dL
(0.93 to 1.7), TSH: 1,3 uIU/mL (0.27 to 4.2), PTH: 26
pg/ml, morning cortisol: 12 μg/dL, LH: 5.5 mIU/ml (1.7
to 8.6), FSH: 12 mIU/ml (1.5 to 12.4), total testosterone:
2.7 ng/ml (2.8 to 8.0), free testosterone: 6.8 pg/ml (9 to
55), sex hormone binding globulin: 80 nmol (20 to 70).
Stool examination for ova and parasites was negative.
Microscopic evaluation of feces did not reveal any blood
or leucocytes. No bacterial growth was observed on
stool cultures. Ileocolonoscopy demonstrated no
abnormality with normal-appearing mucosa. Gastro-
scopic evaluation revealed antral gastritis and insuffi-
ciency of cardioesophageal sphincter. On
histopathological examinations of the upper and lower
gastrointestinal system endoscopic biopsy samples, no
pathology was detected.
Anorectal manometric study showed that internal and
external sphincters were weak with reduced resting and
squeezing anal pressures. Rectal sensation was within
normal limits. Internal anal sphincter relaxed normally
on rectal distension.
External anal sphincter electromyography (EMG)
showed myopathic features and polyphasic high-ampli-
tude motor units. However, myotonia was not observed.
His electrocardiogram demonstrated normal sinus
rhythm with no signs of ischemia. Minimal mitral and
tricuspid valve insufficiencies were reported on echocar-
diography. An X-ray of his lumbosacral vertebrae
showed minimal scoliosis.
EMG showed signs of a myopathic process in the dis-
tal muscles of his extremities. Typical myotonic dis-
charges were recorded. These results are compatible
with MD.
We performed overnight polysomnography which
showed sleep efficiency of 84%; REM phase comprised
6.7% of the sleep; apnea-hypopnea index (AHI) was
23.1%; desaturation index (ODI) was 21.8%, minimum
SaO2 was 82%, mean saturation was 94%. We recom-
mended noninvasive intermittent positive-pressure
ventilation.
Our patient was euthyroidic. Hypotension, hyponatre-
mia, and hyperpotassemia were not noted. Hypothala-
mico-pituitary-adrenal axes were intact. However, the
patient had a history of libido loss and impotence for
three years. Gonadal functions were compatible with
hypogonadotropic hypogonadism. Further endocrine
tests were performed to exclude multiple endocrine neo-
plasia (MEN) syndromes. Serum prolactin, calcium,
parathyroid hormone, calcitonin and gastrin levels, and
24-hour urine catecholamine levels were all in normal
ranges. The patient was started on intramuscular testos-
terone injections of 250 mg monthly. The dose was
adjusted to achieve a total testosterone concentration of
3 to 4 ng/ml (immediately before injection). His gonadal
symptoms improved in a few months.
The final diagnosis of MD was confirmed with genetic
evaluation.
Discussion
Myotonic muscular dystrophy, also called Steinert’s syn-
drome is a systemic disease characterized by myotonia
or difficulty in muscular relaxation, atrophy and weak-
ness of skeletal muscle [4].
Gastrointestinal involvement is frequently observed in
MD patients, and digestive complaints may be the first
sign of the disease. In some patients, the impairment of
gastrointestinal function develops so gradually that they
adapt with little or no awareness of any disturbance;
and only a thorough anamnesis may reveal possible
symptoms [3]. Diarrhea, sometimes accompanied with
malabsorption, steatorrhea, and crampy abdominal pain,
is a frequent complaint in MD patients [6].
Diarrhea and possibly malabsorption have been attrib-
uted to reduced peristaltic activity, leading to bacterial
overgrowth [7]. For the diagnosis of bacterial over-
growth, hydrogen and methane breath tests are the
most important diagnostic methods [8-11]. These tests
have three major drawbacks. First, breath tests them-
selves are not accurate in all situations. Depending on
the substrate used there is the potential, in some
instances, for it to be rapidly absorbed in the proximal
small intestine, leading to a false-negative result and
thereby reducing sensitivity. Second, there is a lack of
consensus as to what threshold should be used to define
a positive test. Third, the gold standard for the diagno-
sis of small intestinal bacterial overgrowth remains jeju-
nal aspirate and culture (12). We did not perform a
hydrogen breath test or jejunal aspirate and culture. It
is well known that norfloxacin and/or cholestyramine
can alleviate this symptom. Prebiotics and probiotics
also exert various beneficial effects in bacterial
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of prebiotics or probiotics in bacterial overgrowth are
limited and it is, therefore, not possible to recommend
them for general clinical use. Our patient was pre-
scribed norfloxacin twice daily which helped control his
the diarrhea. Afterwards, the patient had several courses
of antibiotics.
Diarrhea may be accompanied with fecal inconti-
nence such as occurred with our patient. Anal mano-
metric studies are not frequently performed in MD
patients. A few manometric studies report a decrease
in both the resting and squeezing pressure, which is
consistent with our data [2,13,14]. Treatment of defe-
cation disorders involves rehabilitation, electro-anal sti-
mulation, kinesitherapy, and biofeedback. Abercrombie
JF et al. showed that surgical management of anal
incontinence is unsatisfactory in the long term [2].
Because of this data, we did not recommend anal sur-
gery to our patient.
Cardiac involvement of MD causes conduction
defects, arrhythmias and even sudden death. No correla-
tion was found between the severity of skeletal muscle
involvement and cardiac involvement [15]. In our case,
the patient had no sign of cardiac involvement.
It is well known that Steinert’s syndrome is closely
related to some endocrine diseases, such as diabetes
mellitus, insulin resistance, thyroidal diseases, adrenal
insufficiency, hypogonadotropic hypogonadism and
components of MEN syndromes [16-19].
According to our physical and hormonal examination,
our patient’s gonadal functions were compatible with
hypogonadotropic hypogonadism as a part of Steinert’s
syndrome. He also had bilateral cataract, which is a typi-
cal involvement of the eyes.
There is no disease-modifying therapy available for the
treatment of MD. Thus, treatment is only symptomatic.
The systemic (non-neuromuscular) manifestations of
MD are the most treatable aspects of the disease.
Recommendations regarding management are based
solely on consensus and clinical experience rather than
evidence from randomized controlled trials. Manage-
ment includes multidisciplinary annual follow-up.
Although diarrhea and anal incontinence are common
gastrointestinal complaints in MD patients, MD is a rare
cause of diarrhea and anal incontinence. Thus, a careful
and systemic assessment of the patients is very
important.
Conclusion
In clinical practice, the persistence of diarrhea and fecal
incontinence with muscle weakness should lead the phy-
sician to perform an anal manometric study and EMG.
Neuromuscular disorders such as MD should be consid-
ered in the differential diagnosis.
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